CLINICAL TRIALS PROFILE FOR BMS-986322
✉ Email this page to a colleague
Clinical Trials for BMS-986322
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT04175925 ↗ | A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants | Active, not recruiting | Bristol-Myers Squibb | Phase 1 | A Study assessing the drug levels and drug effects of variable doses of BMS-986322 in Healthy Participants compared to a placebo. The study also assesses how BMS-986322 affects the body with food and its acidity levels. |
| NCT05546151 ↗ | A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent | Not yet recruiting | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to assess the safety and tolerability of multiple ascending oral doses of BMS-986322 in healthy participants of Japanese descent. |
| NCT05579574 ↗ | A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants | Not yet recruiting | Bristol-Myers Squibb | Phase 1 | The purpose of this study is to evaluate the effect of multiple doses of BMS-986322 on the pharmacokinetics (PK) of Loestrin components in healthy female participants. |
| NCT05615012 ↗ | A Study Investigating Interactions Between BMS-986322 and Rosuvastatin or Metformin in Healthy Participants | Not yet recruiting | Bristol-Myers Squibb | Phase 1 | The aim of this study is to assess the effect of coadministration of multiple oral doses of BMS-986322 with rosuvastatin or metformin in healthy participants. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for BMS-986322
Condition Name
Clinical Trial Locations for BMS-986322
Trials by Country
Clinical Trial Progress for BMS-986322
Clinical Trial Phase
Clinical Trial Sponsors for BMS-986322
Sponsor Name
